Wolfgang Wick
Neurology Clinic and Neurooncology Program at the National Center for Tumor Disease, University Hospital Heidelberg, Heidelberg, Germany
Wolfgang Wick is Chairman of the Neurology Clinic and Professor of Neurology at Heidelberg University in Germany and is appointed as Division Head for Neuro Oncology at the German Cancer Research Center, Heidelberg, Germany. He was trained in Tübingen and did his medical studies in Bonn, London and Boston. Dr. Wick is active in basic, translational and clinical research with a translational and basic research focus on precision medicine, treatment resistance and immunotherapy.
Dr. Wick serves as a member of the steering committees of NOA, the European Association for Neuro-Oncology (EANO) and the EORTC Brain Tumor Group and is currently Chair of the NOA, and served as President of EANO 2016-2018 as well as Chair of the EORTC Brain Tumor group 2009-2015. He is Spokesperson of the first Neurooncology Collaborative Research Center in Germany (SFB 1389/UNITE) on Understanding and Targeting Resistance in Glioblastoma.
Dr. Wick (current h-factor 79) has written more than 450 articles for peer-reviewed journals, including Nature, New England Journal of Medicine, Journal of Clinical Oncology, Lancet Oncology, Nature Medicine, Cell Stem Cells and Neuro-Oncology.
Editorial Board
Terms of Appointment: August 2019 - July 2021